| Dr Michael A Israelson, DDS | |
|
275 Century Cir, Louisville, CO 80027-9729 | |
| (303) 666-4499 | |
| Not Available |
| Full Name | Dr Michael A Israelson |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 275 Century Cir, Louisville, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114045648 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 8638 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael A Israelson, DDS 275 Century Cir, Louisville, CO 80027-9729 Ph: (303) 666-4499 | Dr Michael A Israelson, DDS 275 Century Cir, Louisville, CO 80027-9729 Ph: (303) 666-4499 |
News Archive
Experts who have been investigating the World Health Organization's management of the response to the H1N1 pandemic have announced that they found no evidence that the drug industry influenced the agency's decision making over how to handle the virus. In their draft report that panel of independent experts did acknowledge that the WHO failed to understand and respond to conflicts of interest among experts on its advisory Emergency Committee, which had previously acknowledged their pharmaceutical industry ties.
Research carried out at the University of Tartu Faculty of Medicine used nanoparticles for the development of new imaging and treatment methods for peritoneal cancers. Tests showed that precision-guided anticancer nanoparticles have improved efficacy and reduced side effects.
Medivation, Inc. and Astellas Pharma Inc. today announced that patient enrollment was completed on November 15, 2010 in the Phase 3 AFFIRM study of the investigational drug MDV3100, a novel, triple-acting oral androgen receptor antagonist, in patients with advanced prostate cancer who have previously been treated with chemotherapy. The companies also announced that clinical development of MDV3100 in Japan has commenced, with the initiation of patient dosing in a Phase 1-2 clinical study.
Ardea Biosciences, Inc. announced additional positive results from the completed first cohort of an ongoing Phase 2a, proof-of-concept study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout.
Shinya Yamanaka, MD, PhD, a senior investigator at the Gladstone Institutes, next month will receive the Essey Award for his "Commitment to a Cure" from The ALS Association Golden West Chapter.
› Verified 1 days ago
Dr. Brian Frutchey, Dentist Medicare: Not Enrolled in Medicare Practice Location: 850 W South Boulder Rd Unit 201, Louisville, CO 80027 Phone: 303-665-6120 | |
Dr. Laurence J. Colletti, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 1056 S 88th St, Louisville, CO 80027 Phone: 303-666-0800 Fax: 303-604-2995 | |
Dr. Kevin Harrison Moore, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 225 W South Boulder Rd Ste 200, Louisville, CO 80027 Phone: 303-666-5080 | |
Dr. Ashwini Shivashankarappa, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 877 E South Boulder Rd, Louisville, CO 80027 Phone: 720-476-5504 Fax: 303-200-7375 | |
Talbot R Fucci, D.M.D Dentist Medicare: Not Enrolled in Medicare Practice Location: 877 E South Boulder Rd, Louisville, CO 80027 Phone: 303-665-8228 | |
Dr. Thomas J Melcher, D.D.S., M.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 315 W South Boulder Rd Ste 111, Louisville, CO 80027 Phone: 303-666-9717 | |
David Andrew Wertz, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 801 Main St, 220, Louisville, CO 80027 Phone: 303-926-8225 Fax: 303-604-6369 |